We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.25B
AUM Growth
+$136M
Cap. Flow
+$60.6M
Cap. Flow %
4.87%
Top 10 Hldgs %
22.84%
Holding
2,021
New
430
Increased
368
Reduced
444
Closed
703

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$28M
2
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
+$19.2M
3
MON
Monsanto Co
MON
+$12.5M
4
COL
Rockwell Collins
COL
+$10.9M
5
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$9.71M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$30M
2
PRXL
Parexel International Corp
PRXL
+$17.6M
3
LVLT
Level 3 Communications Inc
LVLT
+$14.6M
4
ALR
Alere Inc
ALR
+$13.8M
5
KITE
Kite Pharma, Inc.
KITE
+$8.05M

Sector Composition

Rank Sector Weight
1 Technology 16.16%
2 Communication Services 12.62%
3 Healthcare 9.79%
4 Consumer Discretionary 7.25%
5 Industrials 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LAKE icon
1226
Lakeland Industries
LAKE
$120M
$7K ﹤0.01%
+485
New +$7.14K
LAUR icon
1227
Laureate Education
LAUR
$5.26B
$7K ﹤0.01%
500
– –
XME icon
1228
State Street SPDR S&P Metals & Mining ETF
XME
$4.25B
$7K ﹤0.01%
+196
New +$6.39K
SAFM
1229
DELISTED
Sanderson Farms Inc
SAFM
$7K ﹤0.01%
47
-53
-53% -$8.18K
AMAG
1230
DELISTED
AMAG Pharmaceuticals
AMAG
$7K ﹤0.01%
559
-1,900
-77% -$28.6K
AVX
1231
DELISTED
AVX Corporation
AVX
$7K ﹤0.01%
+384
New +$7.02K
NVTR
1232
DELISTED
Nuvectra Corporation Common Stock
NVTR
$7K ﹤0.01%
+922
New +$9.69K
SYNT
1233
DELISTED
Syntel Inc
SYNT
$7K ﹤0.01%
306
-5,238
-94% -$124K
EFOR
1234
Everforth Inc
EFOR
$1.25B
$6K ﹤0.01%
100
– –
DHX icon
1235
DHI Group
DHX
$180M
$6K ﹤0.01%
3,370
-10,830
-76% -$22.5K
GNE icon
1236
Genie Energy
GNE
$370M
$6K ﹤0.01%
1,419
+1,019
+255% +$5.38K
HBIO icon
1237
Harvard Bioscience
HBIO
$28.8M
$6K ﹤0.01%
+190
New +$6.41K
JBLU icon
1238
JetBlue
JBLU
$2.4B
$6K ﹤0.01%
271
-3,774
-93% -$77.1K
NKTR icon
1239
Nektar Therapeutics
NKTR
$2.47B
$6K ﹤0.01%
6
-1,100
-99% -$651K
EVBG
1240
DELISTED
Everbridge, Inc. Common Stock
EVBG
$6K ﹤0.01%
+200
New +$5.45K
QTRH
1241
DELISTED
Quarterhill Inc. Common Shares
QTRH
$6K ﹤0.01%
+3,331
New +$5.83K
PETX
1242
DELISTED
Aratana Therapeutics, Inc.
PETX
$6K ﹤0.01%
+1,050
New +$6.42K
INSY
1243
DELISTED
Insys Therapeutics, Inc.
INSY
$6K ﹤0.01%
636
-6
-0.9% -$39
FTD
1244
DELISTED
FTD Companies, Inc. Common Stock
FTD
$6K ﹤0.01%
+782
New +$7.27K
AAL icon
1245
American Airlines Group
AAL
$11.1B
$5K ﹤0.01%
99
-5,293
-98% -$264K
AGEN
1246
Agenus
AGEN
$336M
$5K ﹤0.01%
85
-128
-60% -$9.77K
DSGR icon
1247
Distribution Solutions Group
DSGR
$1.61B
$5K ﹤0.01%
400
-1,000
-71% -$12.6K
HSII
1248
DELISTED
Heidrick & Struggles
HSII
$5K ﹤0.01%
200
-4,200
-95% -$98.4K
ICFI icon
1249
ICF International
ICFI
$1.52B
$5K ﹤0.01%
100
-300
-75% -$16.2K
RGS icon
1250
Regis Corp
RGS
$66.8M
$5K ﹤0.01%
15
-45
-75% -$13.8K
48 49
50
51 52

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return

Prelude Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Prelude Capital Management held 2,021 positions worth $1.25B, up 12% from $1.11B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Prelude Capital Management deployed $60.6M of net new capital in Q4 2017, opening 430 new positions and adding to 368 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $7.02M trimmed.

  • Prelude Capital Management's largest Q4 2017 buy was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.
  • Prelude Capital Management added most to NXP Semiconductors in Q4 2017, an estimated $28M increase.
  • Prelude Capital Management's biggest Q4 2017 reduction was Western Digital, cutting an estimated $7.02M.
  • Prelude Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $30M.
  • Prelude Capital Management's ten largest holdings make up 23% of its $1.25B portfolio in Q4 2017.
  • Prelude Capital Management opened 430 new positions and closed 703 in Q4 2017.
  • Prelude Capital Management's portfolio value rose 12% quarter-over-quarter to $1.25B.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.